By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Allegro Ophthalmics LLC 

31473 Rancho Viejo Road, Suite 204

San Juan Capistrano  California  92675  U.S.A.
Phone: 949-940-8130 Fax: 949-940-8121



Company News
Allegro Ophthalmics LLC Names Scott Cooper As Chief Financial Officer And Vice President Of Business Development And Mohamed Genead, MD, As Executive Medical Director 10/21/2015 8:07:29 AM
Allegro Ophthalmics LLC Announces Positive Topline Results From Phase II Trial Evaluating Luminate® In Patients With Vitreomacular Traction Or Vitreomacular Adhesion 7/13/2015 8:12:50 AM
Allegro Ophthalmics LLC Announces Issuance Of U.S. Patent For First-In-Class Integrin Peptide Therapy Candidate Luminate 5/18/2015 10:38:56 AM
Allegro Ophthalmics LLC Begins Phase II Clinical Study Of Luminate® For Non-Proliferative Diabetic Retinopathy 5/4/2015 7:59:13 AM
Allegro Ophthalmics LLC Awarded $2 Million Grant From Helmsley Charitable Trust 2/3/2015 10:49:50 AM
Allegro Ophthalmics LLC And Hanmi Pharmaceutical, Co., Ltd Announce Strategic Investment And Collaboration To Develop And Market Luminate® In The Republic Of Korea And China 1/13/2015 10:41:33 AM
Allegro Ophthalmics LLC Begins Phase 2 Clinical Trial Of Luminate® (ALG-1001) For The Treatment Of Diabetic Macular Edema 10/16/2014 10:50:59 AM
Allegro Ophthalmics LLC Announces Commencement of First Human Subject Study With ALG-1001 to Treat Vitreomacular Traction 11/4/2013 10:56:05 AM
Allegro Ophthalmics LLC and the Helmsley Charitable Trust to Present at Partnering for Cures 10/31/2013 12:27:39 PM
Allegro Ophthalmics LLC Receives FDA IND Approval for Phase 2 Clinical Studies With First in Class Integrin Peptide Therapy ALG-1001 10/9/2013 9:57:11 AM